Gynecologic Cancer InterGroup (GCIG) Consensus Review for Cervical Adenocarcinoma

被引：38
|
作者：
Fujiwara, Hiroyuki [1 ]
Yokota, Harushige [2 ]
Monk, Bradley [3 ]
Treilleux, Isabelle [4 ]
Devouassoux-Shisheboran, Mojgan [5 ]
Davis, Alison [6 ,7 ]
Kim, Jae-Weon [8 ]
Mahner, Sven [9 ]
Stany, Michael [10 ]
Pignata, Sandro [11 ]
Ray-Coquard, Isabelle [4 ]
Fujiwara, Keiichi [12 ]
机构：
[1] Jichi Med Univ, Shimono City, Japan
[2] Saitama Canc Ctr, Saitama, Japan
[3] Univ Arizona, Phoenix, AZ USA
[4] Ctr Leon Berard, F-69373 Lyon, France
[5] Hosp Civils Lyon, Lyon, France
[6] Canberra Hosp, Canberra, ACT, Australia
[7] ANZGOG, Camperdown, NSW, Australia
[8] Seoul Natl Univ, Coll Med, Seoul, South Korea
[9] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[10] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
[11] Ist Nazl Tumori Fdn G Pascale IRCCS, Milan, Italy
[12] Saitama Med Univ, Int Med Ctr, Hidaka City, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
Cervical Cancer; Adenocarcinoma; Pathology; Staging; Clinical management; SQUAMOUS-CELL CARCINOMA; UTERINE CERVIX; ONCOLOGY-GROUP; COMBINATION CHEMOTHERAPY; RADICAL SURGERY; PHASE-III; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; UNITED-STATES; EARLY-STAGE;
D O I：
10.1097/IGC.0000000000000263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.
引用
收藏
页码：S96 / S101
页数：6
相关论文
共 50 条
  • [21] Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/ adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study
    Twu, Nae-Fang
    Ou, Yu-Che
    Liao, Cheng-I
    Chang, Wei-Yang
    Yang, Lan-Yan
    Tang, Yun-Hsin
    Chen, Tze-Chien
    Chen, Chi-Hau
    Chen, Tze-Ho
    Yeh, Lain-Shung
    Hsu, Shih-Tien
    Chen, Yu-Chieh
    Chang, Cheng-Chang
    Cheng, Ya-Min
    Huang, Chia-Yen
    Liu, Fu-Shing
    Lin, Yue-Shan
    Hsiao, Sheng-Mou
    Kan, Yuan-Yee
    Lai, Chyong-Huey
    SURGICAL ONCOLOGY-OXFORD, 2016, 25 (03): : 229 - 235
  • [22] A systematic review and meta-analysis of the prevalence of therapeutic targets in cervical cancer
    Guadalupe Patrono, Maria
    Florencia Calvo, Maria
    Ariel Franco, Juan Victor
    Garrote, Virginia
    Vietto, Valeria
    ECANCERMEDICALSCIENCE, 2021, 15
  • [23] Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience
    Maeda, Michihide
    Hisa, Tsuyoshi
    Kurahashi, Hiroki
    Hayashida, Harue
    Lee, Misooja
    Kakubari, Reisa
    Matsuzaki, Shinya
    Mabuchi, Seiji
    Kamiura, Shoji
    CURRENT ONCOLOGY, 2022, 29 (10) : 7158 - 7170
  • [24] Survey on the Management of Early Cervical Cancer Among Members of the GCIG
    Lindsay, Rhona
    Paul, Jim
    Siddiqui, Nadeem
    Davis, Jonathan
    Gaffney, David K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (09) : 1617 - 1623
  • [25] Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study
    Mitchell, Donald G.
    Snyder, Bradley
    Coakley, Fergus
    Reinhold, Caroline
    Thomas, Gillian
    Amendola, Marco A.
    Schwartz, Lawrence H.
    Woodward, Paula
    Pannu, Harpreet
    Atri, Mostafa
    Hricak, Hedvig
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 95 - 103
  • [26] Surgery for cervical cancer: consensus & controversies
    Poddar, Pabashi
    Maheshwari, Amita
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 154 (02) : 284 - 292
  • [27] The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries
    McCormack, Mary
    Gaffney, David
    Tan, David
    Bennet, Kathy
    Chavez-Blanco, Adriana
    Plante, Marie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (05) : 775 - 778
  • [28] Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
    Lim, Myong Cheol
    Lee, Maria
    Shim, Seung Hyuk
    Nam, Eun Ji
    Lee, Jung Yun
    Kim, Hyun Jung
    Lee, Yoo-Young
    Lee, Kwang Beom
    Park, Jeong Yeol
    Kim, Yun Hwan
    Do Ki, Kyung
    Song, Yong Jung
    Chung, Hyun Hoon
    Kim, Sunghoon
    Lee, Jeong-Won
    Kim, Jae-Weon
    Bae, Duk-Soo
    Lee, Jong-Min
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (03)
  • [29] Comparison of adjuvant chemotherapy and radiotherapy in patients with cervical adenocarcinoma of the uterus after radical hysterectomy: SGSG/TGCU Intergroup surveillance
    Shimada, M.
    Nishimura, R.
    Hatae, M.
    Hiura, M.
    Takehara, K.
    Tase, T.
    Yamada, H.
    Kurachi, H.
    Sugiyama, T.
    Kigawa, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (05) : 425 - 428
  • [30] Discrepancies in Expression and Prognostic Value of Tumor Markers in Adenocarcinoma and Squamous Cell Carcinoma in Cervical Cancer
    Lindstrom, Annika K.
    Tot, Tibor
    Stendahl, Ulf
    Syrjanen, Stina
    Syrjanen, Kari
    Hellberg, Dan
    ANTICANCER RESEARCH, 2009, 29 (07) : 2577 - 2578
12345